X4 Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2018
Total raised
- $99M
Investors
- 7
About X4 Pharmaceuticals
Established in 2012 and based in Boston, US, X4 Pharmaceuticals is a biopharmaceutical company that focuses on developing and marketing drugs for immune system dysfunction disorders. The headquartered in Boston, Massachusetts with a research center of excellence in Vienna, Austria. Dr. Ragan, the company's CEO and president, received her bachelor's degree from Tufts University and her doctorate from the Massachusetts Institute of Technology. She previously served as Chief Commercial Officer at Lysosomal Therapeutics. In March 2019, X4 Pharmaceuticals merged with Arsanis, Inc. (Nasdaq: ASNS). The reverse merger resulted in a combined company operating under the X4 Pharmaceuticals name which commenced trading on the Nasdaq Capital Market under the symbol XFOR and that will focus on the development and commercialization of X4’s lead product candidate, X4P-001, and the advancement of X4’s pipeline of treatments for rare diseases of the immune system and rare cancers. The company focuses on developing drugs for rare diseases and immune system function. Its self-developed products include Mavorixafor and X4P-002. The Mavorixafor for the treatment of WHIM syndrome and waldenströms macroglobulinemia.
Who invested in X4 Pharmaceuticals
7 investors across 3 rounds
See all investors in X4 Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about X4 Pharmaceuticals
Who invested in X4 Pharmaceuticals?
X4 Pharmaceuticals has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has X4 Pharmaceuticals raised?
X4 Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did X4 Pharmaceuticals last raise money?
X4 Pharmaceuticals's most recent round on record is a Series B, in Sep 2018.
What does X4 Pharmaceuticals do?
Established in 2012 and based in Boston, US, X4 Pharmaceuticals is a biopharmaceutical company that focuses on developing and marketing drugs for immune system dysfunction disorders.
Where is X4 Pharmaceuticals headquartered?
X4 Pharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like X4 Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at X4 Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like X4 Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.